Edward D. Wirth
Equibles does not estimate personal net worth.
Get an email with a short summary when Lineage Cell Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LCTX alertsAbout Edward D. Wirth
The proxy statement of Lineage Cell Therapeutics, Inc. reports total compensation of $694,792 for Edward D. Wirth in fiscal 2019, including a base salary of $285,000. Lineage Cell Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lineage Cell Therapeutics, Inc. includes Brian M. Culley (CFO and Board Member), Jill A. Howe (CFO and Board Member), Alexandra Hernandez (Chief Accounting Officer) and 7 others.
Affiliation history
-
Lineage Cell Therapeutics, Inc. (LCTX)
Proxy statement
Current
Company network
Leadership on record at Lineage Cell Therapeutics, Inc.
- Brian M. Culley CFO, Board Member
- Jill A. Howe CFO, Board Member
- Alexandra Hernandez Chief Accounting Officer
- Angus C. Russell Board Member
- Anula Jayasuriya Board Member
- Anula Jayasuriya, M.D., Ph.D., M.B.A. Board Member
- Brian Culley Board Member
- Deborah Andrews Board Member
- Dipti Amin Board Member
- Don Bailey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Lineage Cell Therapeutics, Inc. (LCTX) | III, M.D., Ph.D. Former Chief Medical Officer | $285,000 | $694,792 |
Recent activity
No call appearances or filed executive changes recorded yet.